Fibrillarin Inhibitors represent a significant class of chemical compounds that have garnered attention due to their impact on cellular processes. Fibrillarin, a conserved nucleolar protein, plays a crucial role in several essential cellular functions, primarily in the context of ribosome biogenesis and the processing of small nucleolar RNAs (snoRNAs). These processes are pivotal for maintaining the integrity and functionality of the cell's protein synthesis machinery. The class of Fibrillarin Inhibitors comprises molecules that are designed to interact with fibrillarin, hindering its normal functions. These inhibitors typically target the catalytic activity or binding sites of fibrillarin, disrupting its interactions with snoRNAs or other essential factors involved in ribosome assembly and RNA processing.
Structurally, Fibrillarin Inhibitors vary widely, with different chemical scaffolds and functional groups, but they share the common goal of perturbing fibrillarin's role in ribosomal RNA modification and snoRNA-guided pseudouridylation. By interfering with these processes, these inhibitors may affect the overall ribosome biogenesis pathway, leading to altered cellular translation and growth. Inhibition of fibrillarin could also have downstream effects on other cellular functions, given its role in RNA methylation and the regulation of certain non-coding RNAs. Research into Fibrillarin Inhibitors is still ongoing, with a focus on understanding the precise mechanisms of interaction between these compounds and fibrillarin. The development of highly specific and potent inhibitors is a complex challenge, as any disruption to essential cellular processes could have broad-ranging effects on cell viability. Therefore, researchers aim to carefully elucidate the molecular mechanisms underlying fibrillarin's functions, enabling the design of inhibitors that can selectively modulate its activity without causing detrimental effects on normal cellular processes. Overall, the exploration of Fibrillarin Inhibitors offers insights into the fundamental biology of ribosome biogenesis and RNA processing, paving the way for future scientific discoveries and applications.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB is a compound known for its ability to inhibit RNA polymerase I transcription, indirectly affecting functions associated with fibrillarin within the nucleolus. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $107.00 $416.00 $1248.00 | 35 | |
Leptomycin B is a naturally derived product that indirectly influences fibrillarin by inhibiting nuclear export and interfering with the movement of proteins between the nucleus and cytoplasm. | ||||||
3-Deazaneplanocin, HCl salt | 120964-45-6 | sc-351856 sc-351856A sc-351856B | 1 mg 5 mg 10 mg | $256.00 $612.00 $936.00 | 2 | |
DZNep is known to inhibit enzymes responsible for RNA and DNA methylation, including those related to fibrillarin methylation. This disruption can lead to altered fibrillarin function and ribosome biogenesis. | ||||||